A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic, pharmacodynamic and safety and tolerability profiles of tobacco-free oral nicotine pouches relative to cigarettes

RATIONALE: Tobacco harm reduction (THR) involves encouraging adult smokers who would otherwise continue to smoke to transition to less harmful forms of nicotine delivery. These products must offer adult smokers reduced exposure to chemicals associated with tobacco combustion, satisfactory blood plas...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapman, Fiona, McDermott, Simon, Rudd, Kathryn, Taverner, Victoria, Stevenson, Matthew, Chaudhary, Nveed, Reichmann, Kerstin, Thompson, Joseph, Nahde, Thomas, O’Connell, Grant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217727/
https://www.ncbi.nlm.nih.gov/pubmed/35732751
http://dx.doi.org/10.1007/s00213-022-06178-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217727/
https://www.ncbi.nlm.nih.gov/pubmed/35732751
http://dx.doi.org/10.1007/s00213-022-06178-6

Ejemplares similares